HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$31.83
+0.57 (+1.82%)
Performance
1D
—
1W
—
1M
—
3M
-14.16%
6M
-3.49%
1Y
-10.72%
YTD
-14.85%
Open$31.50
Previous Close$31.26
Day High$31.86
Day Low$31.02
52W High$40.87
52W Low$25.52
Volume—
Avg Volume813.3K
Market Cap1.82B
P/E Ratio11.46
EPS$2.71
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.42
Below
SMA 200
$34.21
Below
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+193.8% upside
Current
$31.83
$31.83
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 847.35M | 674.43M | 502.35M |
| Net Income | 154.83M | 110.91M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 226.00M | 170.89M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |